HHM Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
MCM
CIA
AWM
FP
MFG
AFG
DADC
HCMT
HHM Wealth Advisors's IHE Position: Q2 2026 in Review
HHM Wealth Advisors held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 450 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #403.
HHM Wealth Advisors first reported a position in IHE in Q1 2020 and has held it in 26 quarters since. 58 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- HHM Wealth Advisors held 450 shares of iShares US Pharmaceuticals ETF worth $44.6K as of Q2 2026.
- HHM Wealth Advisors left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #403 holding.
- HHM Wealth Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2020 and has held it in 26 quarters since.
- 58 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.